Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42,079,879
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
10,339,444
-
Shares change
-
+652,025
-
Total reported value, excl. options
-
$29,052,785
-
Value change
-
+$1,719,804
-
Number of buys
-
11
-
Number of sells
-
-4
-
Price
-
$2.81
Significant Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q4 2023
30 filings reported holding NSPR - InspireMD, Inc. - Common Stock, $0.0001 par value as of Q4 2023.
InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,339,444 shares
of 42,079,879 outstanding shares and own 25% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,133,405 shares), Nantahala Capital Management, LLC (2,066,456 shares), MARSHALL WACE, LLP (1,860,405 shares), Soleus Capital Management, L.P. (1,378,128 shares), Rosalind Advisors, Inc. (925,194 shares), Velan Capital Investment Management LP (904,029 shares), PURA VIDA INVESTMENTS, LLC (450,517 shares), MILLENNIUM MANAGEMENT LLC (348,274 shares), MORGAN STANLEY (63,530 shares), and Mesirow Financial Investment Management, Inc. (30,000 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.